Market Place
Sourcing Support
Zenara Pharma Gets FDA Nod for First Generic Sertraline
01 Aug 2025 //
PR NEWSWIRE
AbbVie Celebrates as Skyrizi and Rinvoq Generate Billions
31 Jul 2025 //
BIOSPACE
Radius Wins Patent Case for Osteoporosis Drug TYMLOS
31 Jul 2025 //
PHARMAWEB
Azurity Pharma Launches BRYNOVIN™, First Oral Liquid Sitagliptin
31 Jul 2025 //
PR NEWSWIRE
Protagenic Therapeutics Granted New Japan Patent for Stilbenoid
30 Jul 2025 //
GLOBENEWSWIRE
FDA Reveals 2026 User Fee Rates
30 Jul 2025 //
RAPS
KPRDO Worries Over JAKs Selling Unapproved Generics
29 Jul 2025 //
PHARMABIZ
Amphastar Pharma` Q2 Earnings Conference Call on August 7, 2025
29 Jul 2025 //
ACCESSWIRE
Roche to Investigate Whether Drug can Delay or Prevent Alzheimer
29 Jul 2025 //
REUTERS
Alembic Pharma Gets Final FDA Nod for Carbamazepine ER Tablets
27 Jul 2025 //
INDPHARMAPOST
Trade Experts Say UK FTA Will Enhance Indian Generics
26 Jul 2025 //
PHARMABIZ
Pfizer Completes Licensing Agreement with 3SBio
26 Jul 2025 //
PRESS RELEASE
Lupin Wins US FDA Approvals for Liraglutide and Glucagon
26 Jul 2025 //
EXPRESSPHARMA
Sun, Taro Ink $200 M Deal to Settle Antitrust Litigation
25 Jul 2025 //
FIERCE PHARMA
Zydus Challenges Order Restricting Cancer Drug Production
25 Jul 2025 //
ECONOMICTIMES
Dr Reddy`s Plan to Launch Generic of Novo`s Weight-Loss Drug
24 Jul 2025 //
REUTERS
Viatris Clears Legal Hurdle on Road to Potential Wegovy Generic
24 Jul 2025 //
FIERCE PHARMA
India-UK FTA Boosts India`s Generic Drug, Medical Device Exports
24 Jul 2025 //
ECONOMICTIMES
USFDA Tentatively Approves Zydus Lifesciences` Generic Blood
24 Jul 2025 //
ECONOMICTIMES
Replimune`s Shares Crater as FDA Rejects Melanoma Drug
23 Jul 2025 //
PRESS RELEASE
Akums launches high-strength Paracetamol Oral Suspension
23 Jul 2025 //
EXPRESS PHAMRA
Pharma Firms Anticipate Muted Earnings Growth in Q1 Results
22 Jul 2025 //
BUSINESS STD
Pharma Industry Faces Muted Q1 Earnings Growth as Sales Decline
21 Jul 2025 //
BUSINESS STD
Avenacy Launches Dehydrated Alcohol Injection in US
21 Jul 2025 //
BUSINESSWIRE
Cronus Pharma Launches Butorphic® Injectable in US
21 Jul 2025 //
BUSINESSWIRE
EQT to Acquire Adalvo, a Leading B2B Dossier Developer
19 Jul 2025 //
PR NEWSWIRE
Experts Analyse OBBBA`s impact on Indian pharma industry
17 Jul 2025 //
PHARMABIZ
Novartis boosts FY 2025 core income outlook on robust Q2 sales
17 Jul 2025 //
GLOBENEWSWIRE
India`s Pharma Exports Resilient Amid Global Volatility
17 Jul 2025 //
EXPRESS PHARMA
Lupin launches Loteprednol Etabonate Ophthalmic Suspension in US
17 Jul 2025 //
EXPRESS PHARMA
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
ViiV expands Licence to Allow generic HIV treatment production
15 Jul 2025 //
REUTERS
Aurobindo to Produce, Supply Long Acting HIV Treatment Drug
15 Jul 2025 //
ECONOMICTIMES
FDA Confirms Para IV Patent Litigation for Dextrose Inj
15 Jul 2025 //
FDA
FDA Confirms Para IV Patent Litigation for Vitrakvi Capsules
15 Jul 2025 //
FDA
Novartis Loses Bid to Block Us Entresto Generic Through 2026
14 Jul 2025 //
REUTERS
Sun Pharma Settles Litigation with Incyte Corp Over Leqselvi
14 Jul 2025 //
ECONOMICTIMES
Amphastar Aims to Quadruple Domestic Manufacturing Capacity
14 Jul 2025 //
ACCESSWIRE
Delaware Court Backs Zantac Drugmakers in Cancer Lawsuits
12 Jul 2025 //
REUTERS
Merck Nears $10 Billion Deal for Respiratory Drugmaker Verona
10 Jul 2025 //
PRESS RELEASE
Gilead Enlists Global Fund in Access Campaign for New PrEp Med
10 Jul 2025 //
PRESS RELEASE
Panacea Biotec, Apotex Settle Collaboration Agreement Breach
09 Jul 2025 //
ECONOMICTIMES
US Consumers to Bear High Tariff Impact from Domestic Pharma
09 Jul 2025 //
ECONOMICTIMES
J&J Defeats Generic Drugmakers in Appeal Over Schizophrenia Drug
09 Jul 2025 //
REUTERS
Taiho’s DMD asset misses in phase 3 trial
09 Jul 2025 //
PRESS RELEASE
Akash Kedia Warns of Us Pricing Reform Impact on Indian Pharma
07 Jul 2025 //
PHARMABIZ
Dr Raj Nagarkar discusses acute shortages in Indian healthcare
05 Jul 2025 //
PHARMABIZ
Lupin Gets FDA nod for Loteprednol Etabonate Ophthalmic Gel
03 Jul 2025 //
EXPRESSPHARMA
FDA Confirms Para IV Patent Litigation for Veklury Powder for Inj
03 Jul 2025 //
FDA
Pharmexcil Talks with US on Trade Facilitation, Market Access
02 Jul 2025 //
PHARMABIZ
Cadila Pharmaceuticals launches Bilacad Dex Syrup
02 Jul 2025 //
INDPHARMAPOST
Asahi Kasei Pharma Begins Phase III Study on Cipn Prevention
02 Jul 2025 //
EXPRESSPHARMA
Europe Must Restore Generic Manufacturing Autonomy: Teva Exec
01 Jul 2025 //
FIERCE PHARMA
Alembic Gets US FDA Approval for Doxorubicin Liposome
30 Jun 2025 //
EXPRESSPHARMA
Alembic Announces USFDA Final Approval for Single-Dose Vials
29 Jun 2025 //
INDPHARMAPOST
India`s Biocon Drops Plan to Launch Weight-Loss Drugs in China
27 Jun 2025 //
REUTERS
Lupin receives USFDA approval for Prucalopride Tablets
26 Jun 2025 //
INDPHARMAPOST
Lupin Launches Prucalopride Tablets in U.S.
26 Jun 2025 //
EXPRESSPHARMA
Study: Delaying Authorized Generics Is on The Decline
25 Jun 2025 //
RAPS
DHODH Inhibitors Market to Reach New Heights by 2034 in Oncology
25 Jun 2025 //
PR NEWSWIRE
